Will Moderna's mRNA-1083 vaccine be available on the market by September 30, 2025? | Binary | | | 7 months ago | |
Will major healthcare providers adopt Moderna's mRNA-1083 vaccine by March 31, 2025? | Binary | | | 7 months ago | |
Will Moderna's mRNA-1083 vaccine receive regulatory approval by end of 2024? | Binary | | | 7 months ago | |
Which regulatory body will first approve Moderna's mRNA-1083 vaccine by December 31, 2024? | Categorical | | | 7 months ago | |
Will Moderna's mRESVIA revenue exceed $500 million in Q3 2024? | Binary | | | 7 months ago | |
Will Moderna's mRESVIA have higher market share than GSK and Pfizer combined by end of 2024? | Binary | | | 7 months ago | |
How many doses of mRESVIA will be administered in the 2024-25 RSV season? | Categorical | | | 7 months ago | |
Which will be Moderna's top-selling vaccine by the end of 2024? | Categorical | | | 8 months ago | |
How will Moderna's profit margin change by the end of 2024? | Categorical | | | 8 months ago | |
Will Moderna's RSV vaccine receive FDA approval by the end of 2024? | Binary | | | 8 months ago | |
Will Moderna's annual revenue return to growth by the end of 2025? | Binary | | | 8 months ago | |
Will Moderna's international sales surpass U.S. sales by the end of 2024? | Binary | | | 8 months ago | |
Will Moderna's COVID-19 vaccine revenue exceed $2 billion in 2024? | Binary | | | 2 months ago | |
Will Moderna report a net profit in Q4 2024? | Binary | | | 2 months ago | |
Will Moderna's cash and cash equivalents exceed $10 billion by the end of Q4 2024? | Binary | | | 2 months ago | |
What will be the market share of combination vaccines including Moderna's mRNA-1083 by end of 2025? | Categorical | | | 7 months ago | |
Which age group will primarily receive Moderna's mRNA-1083 vaccine by end of 2025? | Categorical | | | 7 months ago | |
Which company will lead the market penetration in RSV vaccines by end of 2024? | Categorical | | | 7 months ago | |
Will CDC recommend Moderna's mRESVIA for 2024-25 RSV season? | Binary | | | 7 months ago | |
How will Moderna's stock price change by June 30, 2024 post mRESVIA approval? | Categorical | | | 7 months ago | |
Will Moderna report a net profit for 2024? | Binary | | | 2 months ago | |
What will be Moderna's total revenue for 2024? | Categorical | | | 2 months ago | |
Will Moderna achieve its 2024 product sales forecast of $3.0 to $3.5 billion? | Binary | | | 2 months ago | |
What will be the market response to Moderna's RSV vaccine launch? | Categorical | | | 8 months ago | |
What will be the primary source of Moderna's revenue in 2024? | Categorical | | | 2 months ago | |
Will Moderna achieve its 2024 product sales target by year-end? | Binary | | | 2 months ago | |
What will be Moderna's EPS for 2024? | Categorical | | | 2 months ago | |
What will be Moderna's top-selling product in Q4 2024? | Categorical | | | 2 months ago | |
What percentage of Moderna's Q4 2024 revenue will come from COVID-19 vaccines? | Categorical | | | 2 months ago | |
Which COVID-19 vaccine targeting the KP.2 variant will be most effective in reducing viral load by December 31, 2024? | Categorical | | | 3 months ago | |
Will studies confirm that Novavax has fewer side effects than Moderna by December 31, 2024? | Binary | | | 3 months ago | |
Will at least 10 million doses of Moderna's updated KP.2 variant vaccine be administered in the US by December 31, 2024? | Binary | | | 3 months ago | |
Will Moderna's updated KP.2 variant vaccine be available at major retailers by October 31, 2024? | Binary | | | 3 months ago | |
Which COVID-19 vaccine targeting the KP.2 variant will be perceived to have the fewest side effects by the public by December 31, 2024? | Categorical | | | 3 months ago | |
Which COVID-19 vaccine targeting the KP.2 variant will be most administered in the US by December 31, 2024? | Categorical | | | 3 months ago | |
